Fig. 2From: The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mgAdapted from Astrup et al. [35]Change in body weight after treatment of obese individuals with four liraglutide doses (1.2, 1.8, 2.4, or 3.0 mg) or to placebo administered once a day subcutaneously, or orlistat (120 mg) three times a day orally. Data are mean (95% CI) for the ITT population with the last observation carried forward (LOCF)Back to article page